{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:31:51Z","timestamp":1759537911476,"version":"build-2065373602"},"reference-count":86,"publisher":"Informa UK Limited","issue":"13","funder":[{"DOI":"10.13039\/100031478","name":"#NEXTGENERATIONEU","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of University and Research"},{"name":"National Recovery and Resilience Plan","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RICERCA CORRENTE 2024"],"award-info":[{"award-number":["RICERCA CORRENTE 2024"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/14656566.2025.2563279","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:45:28Z","timestamp":1758120328000},"page":"1399-1414","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Navigating regulatory challenges in pediatric epilepsy pharmacotherapy: pathways to safe and effective treatments"],"prefix":"10.1080","volume":"26","author":[{"given":"Gianmichele","family":"Villano","sequence":"first","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Riva","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"IRCCS Istituto \u201cGiannina Gaslini\u201d","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Santangelo","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"IRCCS Istituto \u201cGiannina Gaslini\u201d","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Rose","sequence":"additional","affiliation":[{"name":"Klausrose Consulting","place":["L\u00f6rrach, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"IRCCS Istituto \u201cGiannina Gaslini\u201d","place":["Genoa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3908"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18238"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh726"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17875"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020405"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17241"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17239"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00344"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12717"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807303072"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-85990-1_22"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2006.10.004"},{"key":"e_1_3_5_15_1","volume-title":"Abuse of minors in clinical studies: a worldwide ethical challenge for the 21st century","author":"Rose K","year":"2023","unstructured":"Rose K. Abuse of minors in clinical studies: a worldwide ethical challenge for the 21st century. (UK): Ethics International Press; 2023."},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-6-199503150-00009"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195912242612604"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.55.5.703"},{"key":"e_1_3_5_19_1","unstructured":"United Nations. Un declaration of the rights of the child [Internet]. 1959. Available from: https:\/\/www.humanium.org\/en\/declaration-rights-child-2\/"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/2168479018812060"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMhpr021646"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(68)80414-7"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.59.8.0001"},{"issue":"3","key":"e_1_3_5_24_1","first-page":"635","article-title":"Deception and fraud in the justification of \u201cPediatric Drug Development\u201d: a challenge at the interface of medicine and law","volume":"31","author":"Rose K","year":"2024","unstructured":"Rose K, Grant-Kels JM, Striano P, et al. Deception and fraud in the justification of \u201cPediatric Drug Development\u201d: a challenge at the interface of medicine and law. J Law Med. 2024;31(3):635\u2013644.","journal-title":"J Law Med"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v14.i2.92371"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2016.05.003"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13809"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13859"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.950171"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03157-3"},{"issue":"8","key":"e_1_3_5_31_1","first-page":"155","article-title":"Stiripentol in severe myoclonic epilepsy in infancy (SMEI): a placebo-controlled Italian trial","volume":"43","author":"Guerrini R","year":"2002","unstructured":"Guerrini R, Tonnelier S, d\u2019Athis P, et al. Stiripentol in severe myoclonic epilepsy in infancy (SMEI): a placebo-controlled Italian trial. Epilepsia. 2002;43(Suppl 8):155.","journal-title":"Epilepsia"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-023-01138-2"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2022.2117606"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-024-00798-3"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14670"},{"key":"e_1_3_5_36_1","unstructured":"Nabbout R Auvin S Zuberi S et al. Fintepla (fenfluramine HCl oral solution) reduces convulsive seizure frequency in Dravet syndrome patients receiving antiepileptic drug treatment regimen containing stiripentol: a phase 3 randomized placebo-controlled study. New Orleans (LA); 2018."},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116476"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2023.08.019"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2022.2127089"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.11.022"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12411"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.120.019539"},{"key":"e_1_3_5_43_1","unstructured":"Food and Drug Administration. Pediatric drug development: regulatory considerations \u2014 complying with the Pediatric Research Equity Act and qualifying for pediatric exclusivity under the Best Pharmaceuticals for Children Act Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pediatric-drug-development-regulatory-considerations-complying-pediatric-research-equity-act-and"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics2040364"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0383-y"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0281-8"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.44.s7.1.x"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2022.08.001"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2017.01.006"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2025.2474560"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2024.2362190"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200362"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.01.016"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2024.2326606"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17366"},{"key":"e_1_3_5_56_1","unstructured":"European Medicines Agency. Reflection paper on the use of extrapolation in the development of medicines for paediatrics final Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/adopted-reflection-paper-use-extrapolation-development-medicines-paediatrics-revision-1_en.pdf"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.622510"},{"key":"e_1_3_5_58_1","unstructured":"Food and Drug Administration. Specific requirements on content and format of labeling for human prescription drugs; revision of \u201cpediatric use\u201d subsection in the labeling; final rule [Internet]. 1994. Available from: 21 CFR 201."},{"key":"e_1_3_5_59_1","unstructured":"US Congress. Fda modernization act [internet]. 1997. Available from: 21 U.S.C. \u00a7\u00a7301 et seq."},{"key":"e_1_3_5_60_1","unstructured":"Food and Drug Administration. Table of medicines with new pediatric information. Pediatric labeling changes through September 28 2010 [Internet]. 2010. Available from: https:\/\/fda.gov\/downloads\/Scienceresearch\/Specialtopics\/Pediatrictherapeuticsresearch\/UCm163159.pdf"},{"key":"e_1_3_5_61_1","unstructured":"Food and Drug Administration. Retrospective review of information submitted and actions taken in response to PREA 2003 Available from: https:\/\/www.fda.gov\/media\/78050\/download"},{"key":"e_1_3_5_62_1","unstructured":"F.D.A. Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 2 years of age and older [internet]. Guidance for industry. 2019. Available from: https:\/\/www.fda.gov\/media\/130449\/download"},{"key":"e_1_3_5_63_1","unstructured":"E.M.A. Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders [internet]. 2023. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-treatment-epileptic-disorders-revision-3_en.pdf"},{"key":"e_1_3_5_64_1","unstructured":"European Medicines Agency. Roles and responsibilities of members and alternates rapporteur and peer reviewers experts and observers of the Paediatric Committee (PDCO) (EMEA\/537415\/2008) Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2009\/10\/WC500004754.pdf\/"},{"key":"e_1_3_5_65_1","unstructured":"European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders [internet]. 2018. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-clinical-investigation-medicinal-products-treat-ment-epileptic-disorders-revision-3_en.pdf"},{"key":"e_1_3_5_66_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) [Internet]. 2024. Available from: https:\/\/www.ich.org"},{"key":"e_1_3_5_67_1","unstructured":"International Council for Harmonisation. Ich guideline E11A on paediatric extrapolation Available from: https:\/\/www.ema.europa.eu\/en\/ich-guideline-e11a-pediatric-extrapolation-scientific-guideline"},{"key":"e_1_3_5_68_1","doi-asserted-by":"crossref","unstructured":"Auby P. Worldwide paediatric regulations. Clin Res Paediatr Psychopharmacol [internet]. Elsevier. 2020 [cited 2025 Mar 28]. p. 15\u201338. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780081006160000034","DOI":"10.1016\/B978-0-08-100616-0.00003-4"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.22270\/ijdra.v11i4.635"},{"key":"e_1_3_5_70_1","unstructured":"McCune S. Fda overview of the pediatric legislation [Internet]. 2019. Available from: https:\/\/www.fda.gov\/media\/132890\/download"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001707"},{"key":"e_1_3_5_72_1","unstructured":"European Commission. Study to support the evaluation of the EU orphan regulation. Final report [Internet]. 2019. Available from: https:\/\/health.ec.europa.eu\/system\/files\/2020-08\/orphan-regulation_study_final-report_en_0.pdf"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/2168479018812060"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2022.2045953"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826d5ec0"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17367"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.0829"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32500-0"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714631"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611618"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.4607"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2373350"},{"key":"e_1_3_5_83_1","first-page":"167","volume-title":"Antiepileptic drug dev","author":"Pellock J","year":"1998","unstructured":"Pellock J. Pediatric trials: practical issues. In: French J, Leppik D Dichter M, editors. Antiepileptic drug dev. Philadelphia: Lippincott\u2013Raven Publishers; 1998. p. 167\u2013171."},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2005.03.003"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002083220604"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1712147"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-020-00214-3"},{"issue":"8","key":"e_1_3_5_88_1","first-page":"e166","article-title":"Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy","volume":"5","author":"Rheims S","year":"2008","unstructured":"Rheims S, Cucherat M, Arzimanoglou A, et al. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. Med. 2008;5(8):e166.","journal-title":"Med"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2563279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:34:07Z","timestamp":1759480447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2563279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":86,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/14656566.2025.2563279"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2563279","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"type":"print","value":"1465-6566"},{"type":"electronic","value":"1744-7666"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}